Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:ILI
일자시간출처헤드라인심볼기업
2010/08/1305:07Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
2010/08/0605:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
2010/08/0521:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
2010/08/0520:02Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/07/2205:30Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/06/2606:06Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/06/2119:31Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/05/1405:06Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
2010/05/0519:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
2010/05/0108:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
2010/05/0108:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
2010/05/0105:36Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/05/0102:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
2010/04/1406:04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
2010/04/0905:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
2010/04/0905:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
2010/04/0605:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
2010/04/0205:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
2010/03/2605:13Edgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
2010/03/2005:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
2010/03/1107:11Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
2010/03/0923:46Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
2010/03/0604:52Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
2010/03/0404:04Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/03/0207:00Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/02/2007:03Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
2010/02/0421:00PR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceLSE:ILI
2010/02/0406:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
2010/02/0307:01Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
2010/01/2606:17Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
 검색 관련기사 보기:AMEX:ILI